Status:
WITHDRAWN
REGISTRY for the Use of a Software for Automatic Detection of the Evolution of Aneurysmal Volume and Graft Migration After EVAR (EndoVascular Aneurysm Repair)
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Nurea
Conditions:
Aneurysm Aortic
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this registry is to find and validate a correlation between morphological indicators such as volume sac evolution, graft migration or length between anatomical landmarks with aneurysm...
Eligibility Criteria
Inclusion
- Male or female ≥18 years of age
- Infra-renal Abdominal Aortic Aneurysm (AAA) treated with EVAR
- ≥50mm
- or ≥5mm increase in 6 months
- or surviving Ruptured AAA
- legal capacity to make own decisions, informed of the nature of the registry, has signed non opposition form available for set-up and proper implementation of follow-up visits throughout the duration of the registry
Exclusion
- Advancing Alzheimer's disease or socially dependent patient
- Opposition to the use of their data for this research
- Life expectancy supposed to be inferior to 2 years Pregnant female
Key Trial Info
Start Date :
April 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05964348
Start Date
April 5 2023
End Date
January 31 2024
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux
Bordeaux, France, 33076